Retinitis Pigmentosa Market Insight, Market Size, Epidemiology, Leading Companies, Emerging and Marketed Therapies

Posted on
by

Retinitis Pigmentosa Market Insight, Market Size, Epidemiology, Leading Companies, Emerging and Marketed Therapies

DelveInsight
DelveInsight’s “Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the Retinitis Pigmentosa , historical and forecasted epidemiology as well as the Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on Retinitis Pigmentosa Market Insights, Epidemiology and Market Forecast-2030  

DelveInsight’s “Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast-2030“ report delivers an in-depth understanding of the Retinitis Pigmentosa , historical and forecasted epidemiology as well as the Retinitis Pigmentosa market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

The Retinitis Pigmentosa market report provides current treatment practices, emerging drugs, Retinitis Pigmentosa market share of the individual therapies, current and forecasted Retinitis Pigmentosa market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Retinitis Pigmentosa treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

 

Key benefits of the report
1. Retinitis Pigmentosa market report covers a descriptive overview and comprehensive insight of the Retinitis Pigmentosa epidemiology and Retinitis Pigmentosa market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Retinitis Pigmentosa market report provides insights on the current and emerging therapies.
3. Retinitis Pigmentosa market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Retinitis Pigmentosa market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Retinitis Pigmentosa market.

Request for sample pages here -> https://www.delveinsight.com/sample-request/retinitis-pigmentosa-market

Key points of the report:-

  • Retinitis Pigmentosa Market Size in the 7MM was found to be USD 237.27 million in 2017.
  • Among the 7MM countries, the United States had the highest market size of 56.40% of the total market in 2017.

 

 Drugs covered

  1. 1.           HORA-RPE65
  2. 2.           jCell
  3. 3.           AGN-151597
  4. 4.           Cenegermin
  5. 5.           Renexus
  6. 6.           hRPC

And many others

The key players in Retinitis Pigmentosa market are:

  1. Horama
  2. jCyte
  3. Allergan
  4. Dompé Farmaceutici
  5. Neurotech Pharmaceuticals
  6. ReNeuron Limited

And many others

 

Reimbursement Scenario

Novartis Pharmaceuticals UK has a commercial arrangement with NHS England making the treatment available to the NHS at a discount, the size of which is commercial in confidence.

The Spark therapeutics provides commercial and governance insurance option such as co-pay and if a patient has government insurance, Spark Therapeutics Generation Patient Services can refer them to independent nonprofit 501(c)(3) organizations that may be able to help with out-of-pocket costs.

KOL- Views

  • The high unmet needs associated with the disease have driven vendors to conduct R&D, which has fueled the pipeline for Retinitis Pigmentosa treatment.
  • Gene therapy is a relatively safe means of treatment and is likely to become even safer as the technology for vector delivery advances.
  • The main causes of the late detection of Retinitis Pigmentosa is lack of awareness and ignorance among the patients. 

Table of contents

1. Report Introduction

 

2. Retinitis Pigmentosa Market Overview at a Glance

 

3. Retinitis Pigmentosa Disease Background and Overview

 

4. Retinitis Pigmentosa Epidemiology and Patient Population

 

5. Retinitis Pigmentosa Country-Wise Epidemiology

 

6.1 United States

 

6.2. EU–5

 

6.3. Germany

 

6.4. France

 

6.5. Italy

 

6.6. Spain

 

6.7. United Kingdom

 

6.8. Japan

7. Retinitis Pigmentosa Treatments & Medical Practices

 

8. Retinitis Pigmentosa Emerging Therapies

 

9. Key Cross Competition

9.1. HORA-RPE65 (Horama)

9.2.  jCell (jCyte)

9.3. AGN-151597: Allergan

9.4 Cenegermin: Dompé Farmaceutici

9.5 Renexus (Neurotech Pharmaceuticals)

9.6 hRPC (ReNeuron Limited)

10. Retinitis Pigmentosa Market Size

 

11. 7MM Retinitis Pigmentosa Country-Wise Market Analysis

 

12. United States Market Size

 

13. EU5 Market Size

 

13.1. Germany Market Size

 

13.2. France Market Size

 

13.3. United Kingdom Market Size

 

13.4. Spain Market Size

 

13.5. Italy Market Size

 

14. Japan Market Size

 

15. Retinitis Pigmentosa Report Methodology

 

16. DelveInsight Capabilities

 

17. Disclaimer

 

18. About DelveInsight

 

 

Request for sample pages here -> https://www.delveinsight.com/sample-request/retinitis-pigmentosa-market

 

Related Reports:

Retinitis Pigmentosa – Epidemiology Forecast to 2030

DelveInsight’s Retinitis Pigmentosa Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Retinitis Pigmentosa in the United States, EU5, Japan.

Retinitis Pigmentosa – Pipeline Insights, 2020

Retinitis Pigmentosa Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Retinitis Pigmentosa market.

 

Media Contact
Company Name: DelveInsight
Contact Person: Priya Maurya
Email: Send Email
Phone: +919650213330
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/